Argent Biopharma (H5O0) Stock Statistics & Valuation Metrics

Argent Biopharma has a market cap or net worth of €2.15M. The enterprise value is €12.72.

Argent Biopharma has 116,609,580 shares outstanding. The number of shares has decreased by -2.65% in one year.

Argent Biopharma’s return on equity (ROE) is 0.82 and return on invested capital (ROIC) is -5166.99%.

The current PE Ratio of Argent Biopharma is ―. Argent Biopharma’s PEG ratio is 0.00568.

In the last 12 months, Argent Biopharma had revenue of 161.19K and earned -7.71M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -9.62M and capital expenditures -2.40K, giving a free cash flow of -9.63M billion.

Argent Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Argent Biopharma upcoming earnings date is Mar 3, 2027, Before Open (Confirmed).

Argent Biopharma as a current ratio of 0.05, with Debt / Equity ratio of ―

In the past 12 months, Argent Biopharma has paid 0.00 in taxes.

Argent Biopharma EV to EBITDA ratio is -1.74, with an EV/FCF ratio of -3.12.

Argent Biopharma has €141.46K in cash and marketable securities with €9.59M in debt, giving a net cash position of -€9.45M billion.

Gross margin is ―, with operating margin of -4586.90%, and net profit margin of -4783.36%.

The average price target for Argent Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―